Search

for
Search:

GlossaryDipeptidyl Peptidase-4 Inhibitors

block the enzyme DPP-4 to help regulate blood sugar

Dipeptidyl Peptidase-4 Inhibitors, often abbreviated as DPP-4 inhibitors, are a class of oral medications used to manage type 2 diabetes. They work by blocking the enzyme DPP-4, which results in increased levels of incretin hormones. These hormones help to regulate blood sugar by increasing insulin release and decreasing glucagon levels, particularly after meals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 180 results

research Cardiovascular Profile of Pharmacological Agents Used for the Management of Polycystic Ovary Syndrome

4 citations , January 2019 in “Therapeutic Advances in Endocrinology and Metabolism”

Medications for PCOS don't seem to raise heart disease risk.

research Linagliptin-Associated Alopecia and Bullous Pemphigoid

7 citations , September 2019 in “European Journal of Case Reports in Internal Medicine”

Linagliptin may cause hair loss and skin blisters.

research Teneligliptin-Induced Hair Loss: A Case Report

4 citations , January 2020 in “Journal of family medicine and primary care”

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

research Unmet Medical Needs in Chronic, Non-Communicable Inflammatory Skin Diseases

59 citations , June 2022 in “Frontiers in medicine”

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

research The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites

19 citations , July 2018 in “Medicines”

Juniperus plants contain compounds with potential for developing various medical treatments.

View more "dipeptidyl peptidase iv inhibitors" in research →

Community Join

0 / 0 results

— no results